Spindle proteins Aurora A and BUB1B, but not Mad2, are aberrantly expressed in dysplastic mucosa of patients with longstanding ulcerative colitis

Journal of Clinical Pathology

Volumn 60, Issue 12, 2007, Pages 1403-1408

  Burum Auensen, Espen ^a   DeAngelis, P M ^a   Schjolberg A R ^a   Røislien, Jo ^a   Andersen, S N ^b   Clausen, O P F ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b AKERSHUS UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AURORA A KINASE; KI 67 ANTIGEN; NUCLEIC ACID BINDING PROTEIN; PROTEIN BUB1B; PROTEIN MAD2; UNCLASSIFIED DRUG;

ANEUPLOIDY; ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; COLON MUCOSA; COLON RESECTION; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSPLASIA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PLOIDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TISSUE MICROARRAY; ULCERATIVE COLITIS;

CALCIUM-BINDING PROTEINS; CELL CYCLE PROTEINS; COLECTOMY; COLITIS, ULCERATIVE; COLONIC NEOPLASMS; DISEASE PROGRESSION; DNA, NEOPLASM; HUMANS; INTESTINAL MUCOSA; KI-67 ANTIGEN; NEOPLASM PROTEINS; PLOIDIES; PRECANCEROUS CONDITIONS; PROTEIN-SERINE-THREONINE KINASES; REPRESSOR PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 37049039447     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2006.044305     Document Type: Article

References (45)

1. MacDougall IP. The cancer risk in ulcerative colitis. Lancet 1964;19:655-8.
2. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001;48:526-35.
3. Gyde S, Prior P, Dew MJ, et al. Mortality in ulcerative colitis. Gastroenterology 1982;83:36-43.
4. Chambers WM, Warren BF, Jewell DP, et al. Cancer surveillance in ulcerative colitis. Br J Surg 2005;92:928-36.
5. Ullman T, Croog V, Harpaz N, et al. Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis. Gastroenterology 2003;125:1311-19.
6. Befrits R, Ljung T, Jaramillo E, et al. Low-grade dysplasia in extensive, long-standing inflammatory bowel disease: a follow-up study. Dis Colon Rectum 2002;145:615-20.
7. Jonsson B, Ahsgren L, Andersson LO, et al. Colorectal cancer surveillance in patients with ulcerative colitis. Br J Surg 1994;81:689-91.
8. Winawer SJ, Fletcher RH, Miller L, et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 1997;112:594-642.
9. Meling GI, Clausen OP, Bergan A, et al. Flow cytometric DNA ploidy pattern in dysplastic mucosa, and in primary and metastatic carcinomas in patients with longstanding ulcerative colitis. Br J Cancer 1991;64:339-44.
10. Rubin CE, Haggitt RC, Burmer GC, et al. DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis. Gastroenterology 1992;103:1611-20.
11. Itzkowitz S. Colon carcinogenesis in inflammatory bowel disease: applying molecular genetics to clinical practice. J Clin Gastroenterol 2003;36:S70-4.
12. Lindberg JO, Stenling RB, Rutegard JN. DNA aneuploidy as a marker of premalignancy in surveillance of patients with ulcerative colitis. Br J Surg 1999;86:947-50.
13. Lofberg R, Lindquist K, Veress B, et al. Highly malignant carcinoma in chronic ulcerative colitis without preceding dysplasia or DNA aneuploidy. Report of a case. Dis Colon Rectum 1992;35:82-6.
14. Kops GJ, Foltz DR, Cleveland DW. Lethality to human cancer cells through massive chromosome loss by inhibition of the mitotic checkpoint. Proc Natl Acad Sci USA 2004;101:8699-704.
15. Giet R, Petretti C, Prigent C. Aurora kinases, aneuploidy and cancer, a coincidence or a real link? Trends Cell Biol 2005;15:241-50.
16. Zhou H, Kuang J, Zhong L, et al. Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nat Genet 1998;20:189-93.
17. Riddell RH, Goldman H, Ransohoff DF, et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol 1983;14:931-68.
18. Burum-Auensen E, De Angelis PM, Schjolberg AR, et al. Subcellular localization of the spindle proteins Aurora A. Mad2, ana BUBRI assessed by immunohistochemistry. J Histochem Cytochem 2007;55:477-86.
19. Camp RL, Charette LA, Rimm DL. Validation of tissue microarray technology in breast carcinoma. Lab Invest 2000;80:1943-9.
20. Vindeløv LL, Christensen IJ, Nissen NI. A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 1983;3:323-7.
21. Clausen OP, Andersen SN, Stromkjaer H, et al. A strategy combining flow sorting and comparative genomic hybridization for studying genetic aberrations at different stages of colorectal tumorigenesis in ulcerative colitis. Cytometry 2001;43:46-54.
22. Willenbucher RF, Aust DE, Chang CG, et al. Genomic instability is an early event during the progression pathway of ulcerative-colitis-related neoplasia. Am J Pathol 1999;154:1825- 30.
23. Rabinovitch PS, Dziadon S, Brentnall TA, et al. Pancolonic chromosomal instability precedes dysplasia and cancer in ulcerative colitis. Cancer Res 1999;59:5148-53.
24. Itzkowitz SH, Yio X. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol 2004;287:G7-17.
25. Anand S, Penrhyn-Lowe S, Venkitaraman AR. AURORA-A amplification overrides the mitotic spindle assembly checkpoint, inducing resistance to Taxol. Cancer Cell 2003;3:51-62.
26. Warner SL, Bearss DJ, Han H, et al. Targeting Aurora-2 kinase in cancer. Mol Cancer Ther 2003;2:589-95.
27. Yang H, Ou CC, Feldman RI, et al. Aurora-A kinase regulates telomerase activity through c-Myc in human ovarian and breast epithelialcells. Cancer Res 2004;64:463-7.
28. Cahill DP, Lengauer C, Yu J, et al. Mutations of mitotic checkpoint genes in human cancers. Nature 1998;392:300-3.
29. Musio A, Montagna C, Zambroni D, et al. Inhibition of BUB1 results in genomic instability and anchorage-independent growth of normal human fibroblasts. Cancer Res 2003;63:2855-63.
30. Rao CV, Yang YM, Swamy MV, et al. Colonic tumorigenesis in BubR1+/-ApcMin/+ compound mutant mice is linked to premature separation of sister chromatids and enhanced genomic instability. Proc Natl Acad Sci USA 2005;102:4365-70.
31. Pati D, Haddad BR, Haegele A, et al. Hormone-induced chromosomal instability in p53-null mammary epithelium. Cancer Res 2004;64:5608-16.
32. Doak SH, Jenkins GJ, Parry EM, et al. Differential expression of the MAD2, BUB1 and HSP27 genes in Barrett's oesophagus - their association with aneuploidy and neoplastic progression. Mutat Res 2004;547:133-44.
33. Mayer F, Stoop H, Sen S, et al. Aneuploidy of human testicular germ cell rumors is associated with amplification of centrosomes. Oncogene 2003;22:3859-66.
34. Collins RH Jr, Feldman M, Fordtran JS. Colon cancer, dysplasia, and surveillance in patients with ulcerative colitis. A critical review. N Engl J Med 1987;316:1654-8.
35. Takahashi T, Futamura M, Yoshimi N, et al. Centrosomal kinases, HsAIRK1 and HsAIRK3, are overexpressed in primary colorectal cancers. Jpn J Cancer Res 2000;91:1007-14.
36. Hoque A, Carter J, Xia W, et al. Loss of aurora A/STK15/BTAK overexpression correlates with transition of in situ to invasive ductal carcinoma of the breast. Cancer Epidemiol Biomarkers Prev 2003;12:1518-22.
37. Gritsko TM, Coppola D, Paciga JE, et al. Activation and overexpression of centrosome kinase BTAK/Aurora-A in human ovarian cancer. Clin Cancer Res 2003;9:1420-6.
38. Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nat Med 2004;10:789-99.
39. Jallepalli PV, Lengauer C. Chromosome segregation and cancer: cutting through the mystery. Nat Rev Cancer 2001;1:109-17.
40. Amon A. The spindle checkpoint. Curr Opin Genet Dev 1999;9:69-75.
41. Sudakin V, Chan GK, Yen TJ. Checkpoint inhibition of the APC/C in HeLa cells is mediated by a complex of BUBR1, BUB3, CDC20, and MAD2. J Cell Biol 2001;154:925-36.
42. Poelzl G, Kasai Y, Mochizuki N, et al. Specific association of estrogen receptor beta with the cell cycle spindle assembly checkpoint protein, MAD2. Proc Natl Acad Sci USA 2000;97:2836-9.
43. Campbell MS, Chan GK, Yen TJ. Mitotic checkpoint proteins HsMAD1 and HSMAD2 are associated with nuclear pore complexes in interphase. J Cell Sci 2001;114:953-63.
44. Shin HJ, Baek KH, Jeon AH, et al. Dual roles of human BubR1, a mitotic checkpoint kinase, in the monitoring of chromosomal instability. Cancer Cell 2003;4:483-97.
45. Fang Y, Liu T, Wang X, et al. BubR1 is involved in regulation of DNA damage responses. Oncogene 2006;25:3598-605.